clinogen medical ltd
clinogen medical ltd Company Information
Company Number
03535145
Website
www.clinogen.comRegistered Address
the dairy house moneyrow green, holyport, maidenhead, berkshire, SL6 2ND
Industry
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Telephone
01628674644
Next Accounts Due
December 2024
Group Structure
View All
Directors
Parmod Jolly26 Years
Shareholders
parmod kumar jolly 55%
sapna jolly 45%
clinogen medical ltd Estimated Valuation
Pomanda estimates the enterprise value of CLINOGEN MEDICAL LTD at £50.7k based on a Turnover of £135k and 0.38x industry multiple (adjusted for size and gross margin).
clinogen medical ltd Estimated Valuation
Pomanda estimates the enterprise value of CLINOGEN MEDICAL LTD at £0 based on an EBITDA of £-17k and a 3.06x industry multiple (adjusted for size and gross margin).
clinogen medical ltd Estimated Valuation
Pomanda estimates the enterprise value of CLINOGEN MEDICAL LTD at £93.5k based on Net Assets of £41.2k and 2.27x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Clinogen Medical Ltd Overview
Clinogen Medical Ltd is a live company located in maidenhead, SL6 2ND with a Companies House number of 03535145. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in March 1998, it's largest shareholder is parmod kumar jolly with a 55% stake. Clinogen Medical Ltd is a mature, micro sized company, Pomanda has estimated its turnover at £135k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Clinogen Medical Ltd Health Check
Pomanda's financial health check has awarded Clinogen Medical Ltd a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
2 Strong
2 Regular
6 Weak
Size
annual sales of £135k, make it smaller than the average company (£1.6m)
- Clinogen Medical Ltd
£1.6m - Industry AVG
Growth
3 year (CAGR) sales growth of -25%, show it is growing at a slower rate (5.5%)
- Clinogen Medical Ltd
5.5% - Industry AVG
Production
with a gross margin of 24.3%, this company has a higher cost of product (44.7%)
- Clinogen Medical Ltd
44.7% - Industry AVG
Profitability
an operating margin of -12.6% make it less profitable than the average company (6.4%)
- Clinogen Medical Ltd
6.4% - Industry AVG
Employees
with 1 employees, this is below the industry average (15)
- Clinogen Medical Ltd
15 - Industry AVG
Pay Structure
on an average salary of £47.1k, the company has an equivalent pay structure (£47.1k)
- Clinogen Medical Ltd
£47.1k - Industry AVG
Efficiency
resulting in sales per employee of £135k, this is more efficient (£110.6k)
- Clinogen Medical Ltd
£110.6k - Industry AVG
Debtor Days
it gets paid by customers after 135 days, this is later than average (57 days)
- Clinogen Medical Ltd
57 days - Industry AVG
Creditor Days
its suppliers are paid after 33 days, this is close to average (33 days)
- Clinogen Medical Ltd
33 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Clinogen Medical Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Clinogen Medical Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 18.5%, this is a lower level of debt than the average (52%)
18.5% - Clinogen Medical Ltd
52% - Industry AVG
CLINOGEN MEDICAL LTD financials
Clinogen Medical Ltd's latest turnover from March 2023 is estimated at £135 thousand and the company has net assets of £41.2 thousand. According to their latest financial statements, we estimate that Clinogen Medical Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||||||
| Other Income Or Grants | ||||||||||||||
| Cost Of Sales | ||||||||||||||
| Gross Profit | ||||||||||||||
| Admin Expenses | ||||||||||||||
| Operating Profit | ||||||||||||||
| Interest Payable | ||||||||||||||
| Interest Receivable | ||||||||||||||
| Pre-Tax Profit | ||||||||||||||
| Tax | ||||||||||||||
| Profit After Tax | ||||||||||||||
| Dividends Paid | ||||||||||||||
| Retained Profit | ||||||||||||||
| Employee Costs | ||||||||||||||
| Number Of Employees | ||||||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 350 | 467 | 622 | 778 | 972 | 1,340 | 2,144 | 1,899 | 2,374 | 2,968 | 3,710 | 13,487 | 23,495 | 33,793 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,125 | 1,625 | 2,125 | 2,625 | 3,125 | 3,625 | 4,125 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 350 | 467 | 622 | 778 | 972 | 1,340 | 2,144 | 3,024 | 3,999 | 5,093 | 6,335 | 16,612 | 27,120 | 37,918 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 175 | 175 | 175 | 175 | 175 | 425 | 525 |
| Trade Debtors | 50,232 | 68,610 | 76,561 | 108,501 | 88,553 | 70,012 | 64,943 | 0 | 0 | 0 | 0 | 0 | 168 | 168 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 93,709 | 81,870 | 61,440 | 55,863 | 34,965 | 31,741 | 51,921 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 50,232 | 68,610 | 76,561 | 108,501 | 88,553 | 70,012 | 64,943 | 93,884 | 82,045 | 61,615 | 56,038 | 35,140 | 32,334 | 52,614 |
| total assets | 50,582 | 69,077 | 77,183 | 109,279 | 89,525 | 71,352 | 67,087 | 96,908 | 86,044 | 66,708 | 62,373 | 51,752 | 59,454 | 90,532 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 9,367 | 10,873 | 17,288 | 36,450 | 10,358 | 7,350 | 7,861 | 15,325 | 20,690 | 19,384 | 17,525 | 8,350 | 8,390 | 10,712 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,606 | 3,606 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3,591 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 9,367 | 10,873 | 17,288 | 36,450 | 10,358 | 7,350 | 7,861 | 15,325 | 20,690 | 19,384 | 17,525 | 11,956 | 11,996 | 14,303 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 9,367 | 10,873 | 17,288 | 36,450 | 10,358 | 7,350 | 7,861 | 15,325 | 20,690 | 19,384 | 17,525 | 11,956 | 11,996 | 14,303 |
| net assets | 41,215 | 58,204 | 59,895 | 72,829 | 79,167 | 64,002 | 59,226 | 81,583 | 65,354 | 47,324 | 44,848 | 39,796 | 47,458 | 76,229 |
| total shareholders funds | 41,215 | 58,204 | 59,895 | 72,829 | 79,167 | 64,002 | 59,226 | 81,583 | 65,354 | 47,324 | 44,848 | 39,796 | 47,458 | 76,229 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | ||||||||||||||
| Depreciation | 475 | 594 | 742 | 9,777 | 10,008 | 10,298 | 10,660 | |||||||
| Amortisation | 500 | 500 | 500 | 500 | 500 | 500 | ||||||||
| Tax | ||||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | -175 | 0 | 0 | 0 | 0 | -250 | -100 | 525 |
| Debtors | -18,378 | -7,951 | -31,940 | 19,948 | 18,541 | 5,069 | 64,943 | 0 | 0 | 0 | 0 | -168 | 0 | 168 |
| Creditors | -1,506 | -6,415 | -19,162 | 26,092 | 3,008 | -511 | -7,464 | -5,365 | 1,306 | 1,859 | 9,175 | -40 | -2,322 | 10,712 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3,606 | 0 | 3,606 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3,591 | 3,591 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | ||||||||||||||
| cash flow from financing | ||||||||||||||
| cash and cash equivalents | ||||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | -93,709 | 11,839 | 20,430 | 5,577 | 20,898 | 3,224 | -20,180 | 51,921 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | -93,709 | 11,839 | 20,430 | 5,577 | 20,898 | 3,224 | -20,180 | 51,921 |
clinogen medical ltd Credit Report and Business Information
Clinogen Medical Ltd Competitor Analysis
Perform a competitor analysis for clinogen medical ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in SL6 area or any other competitors across 12 key performance metrics.
clinogen medical ltd Ownership
CLINOGEN MEDICAL LTD group structure
Clinogen Medical Ltd has no subsidiary companies.
Ultimate parent company
CLINOGEN MEDICAL LTD
03535145
clinogen medical ltd directors
Clinogen Medical Ltd currently has 1 director, Mr Parmod Jolly serving since Mar 1998.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Parmod Jolly | United Kingdom | 81 years | Mar 1998 | - | Director |
P&L
March 2023turnover
135k
-24%
operating profit
-17k
0%
gross margin
24.3%
+3.37%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
41.2k
-0.29%
total assets
50.6k
-0.27%
cash
0
0%
net assets
Total assets minus all liabilities
clinogen medical ltd company details
company number
03535145
Type
Private limited with Share Capital
industry
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
March 1998
age
26
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2023
previous names
depeche mode laboratories limited (January 2013)
accountant
-
auditor
-
address
the dairy house moneyrow green, holyport, maidenhead, berkshire, SL6 2ND
Bank
-
Legal Advisor
-
clinogen medical ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to clinogen medical ltd.
clinogen medical ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
